LifeMD PE Ratio 2011-2024 | LFMD
Current and historical p/e ratio for LifeMD (LFMD) from 2011 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. LifeMD PE ratio as of May 01, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| LifeMD PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-05-02 | 7.25 | 0.00 | |
| 2024-12-31 | 4.95 | $-0.54 | 0.00 |
| 2024-09-30 | 5.24 | $-0.64 | 0.00 |
| 2024-06-30 | 6.86 | $-0.70 | 0.00 |
| 2024-03-31 | 10.28 | $-0.74 | 0.00 |
| 2023-12-31 | 8.29 | $-0.70 | 0.00 |
| 2023-09-30 | 6.25 | $-0.98 | 0.00 |
| 2023-06-30 | 4.35 | $-1.04 | 0.00 |
| 2023-03-31 | 1.70 | $-1.26 | 0.00 |
| 2022-12-31 | 1.94 | $-1.57 | 0.00 |
| 2022-09-30 | 1.97 | $-1.79 | 0.00 |
| 2022-06-30 | 2.04 | $-2.07 | 0.00 |
| 2022-03-31 | 3.53 | $-2.26 | 0.00 |
| 2021-12-31 | 3.87 | $-2.27 | 0.00 |
| 2021-09-30 | 6.21 | $-4.21 | 0.00 |
| 2021-06-30 | 11.78 | $-5.32 | 0.00 |
| 2021-03-31 | 15.82 | $-4.98 | 0.00 |
| 2020-12-31 | 6.53 | $-4.76 | 0.00 |
| 2020-09-30 | 8.25 | $-2.25 | 0.00 |
| 2020-06-30 | 1.50 | $-0.70 | 0.00 |
| 2020-03-31 | 1.05 | $-0.50 | 0.00 |
| 2019-12-31 | 0.60 | $-0.35 | 0.00 |
| 2019-09-30 | 0.85 | $-0.30 | 0.00 |
| 2019-06-30 | 0.55 | $-0.25 | 0.00 |
| 2019-03-31 | 0.75 | $-0.20 | 0.00 |
| 2018-12-31 | 0.70 | $-0.05 | 0.00 |
| 2018-09-30 | 1.00 | $-0.05 | 0.00 |
| 2018-06-30 | 1.10 | $-0.10 | 0.00 |
| 2018-03-31 | 1.40 | $0.05 | 28.00 |
| 2017-12-31 | 1.70 | $-0.15 | 0.00 |
| 2017-09-30 | 2.15 | $-0.15 | 0.00 |
| 2017-06-30 | 1.50 | $-0.10 | 0.00 |
| 2017-03-31 | 2.50 | $-0.25 | 0.00 |
| 2016-12-31 | 1.30 | $-0.10 | 0.00 |
| 2016-09-30 | 1.30 | $-0.10 | 0.00 |
| 2016-06-30 | 1.30 | $-0.05 | 0.00 |
| 2016-03-31 | 1.50 | 0 | 0.00 |
| 2015-12-31 | 0.60 | 0 | 0.00 |
| 2015-09-30 | 0.25 | 0 | 0.00 |
| 2015-06-30 | 0.45 | 0 | 0.00 |
| 2015-03-31 | 0.90 | 0 | 0.00 |
| 2014-12-31 | 0.50 | 0 | 0.00 |
| 2014-09-30 | 0.65 | 0 | 0.00 |
| 2014-06-30 | 0.70 | 0 | 0.00 |
| 2014-03-31 | 1.25 | 0 | 0.00 |
| 2013-12-31 | 1.30 | 0 | 0.00 |
| 2013-09-30 | 1.30 | 0 | 0.00 |
| 2013-06-30 | 1.45 | 0 | 0.00 |
| 2013-03-31 | 0.65 | 0 | 0.00 |
| 2012-12-31 | 0.80 | 0 | 0.00 |
| 2012-09-30 | 0.90 | 0 | 0.00 |
| 2012-06-30 | 0.80 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.327B | $0.212B |
| LifeMD Inc. is a telehealth company. It offers a full portfolio of direct-to-patient products and services. The company combines virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers. LifeMD Inc., formerly known as Conversion Labs, is based in NEW YORK. | |||